Diagnostics services company Thyrocare Technologies reported a 12% Q-o-Q increase in revenues to Rs. 165 Cr in Q1FY22 and a 49% Y-o-Y increase in Profit after Tax to Rs. 55.87 Cr. The growth in revenues was driven by increased testing during the Covid second wave which was rampant in the country during the quarter.
You like to know more. We like that!
Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs 7499/Year.
Please login to view this free article.
This blog is available only for logged in users, please register and get access to view this article.